GeneSight Pharmacogenomic Testing
Psychiatric medications can affect people differently. GeneSight Psychotropic is a pharmacogenomic test that analyzes certain genetic variations that may provide additional information about how your body processes or responds to some medications used in mental-health treatment. At RayMex Wellness, GeneSight results are reviewed together with your symptoms, diagnosis, treatment history, current medications, medical history, and previous medication response.
Important: GeneSight testing does not identify a guaranteed effective medication and does not replace psychiatric evaluation or clinical judgment.
Who May Benefit?
Pharmacogenomic testing is not part of every psychiatric treatment plan, and it is not something every patient needs. Your psychiatric provider may discuss GeneSight testing when additional medication information could be helpful. Examples may include patients who:
- Have tried multiple psychiatric medications without satisfactory improvement
- Have experienced significant medication side effects
- Have had difficulty tolerating antidepressants or other psychiatric medications
- Have a complicated psychiatric medication history
- Are considering another medication after previous treatment failures
- Want additional pharmacogenomic information as part of a comprehensive medication-management evaluation
Whether testing is appropriate is a clinical decision made with your provider during a psychiatric evaluation and medication-management visit.
How GeneSight Testing Works
Four steps, from your first psychiatric consultation through reviewing the report together.
- 1
Psychiatric consultation
A RayMex provider evaluates your symptoms, diagnoses, medication history, current medications, previous treatment response, and whether pharmacogenomic testing may be clinically useful.
- 2
Cheek swab
GeneSight uses a simple cheek-swab sample. Testing may be completed through a clinician or, when available and appropriate, through an at-home collection process.
- 3
Laboratory analysis
The sample is sent to GeneSight’s laboratory for pharmacogenomic analysis. Results are typically returned to the ordering clinician within a few business days after the laboratory receives and processes the sample, though timing can vary.
- 4
Results review
Your psychiatric provider reviews the report with you and determines how, if at all, the information should influence your treatment plan.
What the Report Means
The GeneSight Psychotropic report organizes medications according to available gene-drug interaction information. Your clinician interprets these findings together with your complete clinical picture. The report uses categories such as:
Use as directed
No gene-drug interaction was identified based on the genes analyzed. This does not mean the medication is guaranteed to work or to be well tolerated.
Moderate gene-drug interaction
The report flags a gene-drug interaction that your clinician may wish to consider. It is information to weigh, not an instruction.
Significant gene-drug interaction
The report flags a more pronounced gene-drug interaction. Your clinician interprets what, if anything, this means for your specific situation.
These categories reflect gene-drug interaction information only. They do not independently tell you which medication to start or stop.
Never start, stop, or change a psychiatric medication solely because of a GeneSight report without discussing the change with your prescribing clinician.
What GeneSight Testing Cannot Determine
Being clear about the limits of a test is part of responsible care. GeneSight does not:
- Diagnose depression, ADHD, anxiety, bipolar disorder, PTSD, or another psychiatric disorder
- Guarantee that a particular medication will work
- Guarantee that a medication will not cause side effects
- Identify every possible medication interaction
- Replace psychiatric assessment
- Replace medication monitoring
- Replace patient preference or shared decision-making
Genetics is one piece of the medication-selection process, alongside diagnosis, previous medication response, side effects, medical history, current medications, age, clinical presentation, and clinician judgment.
Conditions and Medications
GeneSight information may be relevant to medications commonly considered in the treatment of conditions such as depression, anxiety, ADHD, and other psychiatric disorders. The GeneSight Psychotropic report categorizes more than 60 mental-health medications according to gene-drug interaction information.
GeneSight does not treat these conditions. Treatment happens through psychiatric evaluation, medication management, psychotherapy when clinically appropriate, and ongoing monitoring with your provider.
Cost and Insurance
Coverage and patient responsibility vary by insurance plan and medical necessity. Our team can help patients understand the ordering process, while GeneSight/Myriad determines laboratory billing and financial-assistance eligibility.
Some government and commercial insurance plans cover pharmacogenomic testing. Because laboratory pricing and assistance programs are set by the manufacturer and can change, please review GeneSight’s current cost and coverage information directly.
For questions about the psychiatric visit itself, you can check whether we accept your insurance.
GeneSight Testing FAQ
What is GeneSight testing?
GeneSight Psychotropic is a clinician-ordered pharmacogenomic test that analyzes certain genetic variations that may affect how a person metabolizes or responds to some psychiatric medications.
Does GeneSight tell my provider which medication will work?
No. GeneSight provides additional pharmacogenomic information that your provider interprets alongside your diagnosis, treatment history, symptoms, medical history, medications, and previous medication response.
Does the test require blood?
No. GeneSight testing uses a cheek-swab DNA sample.
How long do results take?
Results are generally available to the ordering clinician within a few business days after the laboratory receives and processes the sample. Timing may vary.
Can I take the test at home?
In some cases, a clinician can arrange an at-home GeneSight collection kit. Availability and appropriateness should be confirmed with your provider.
Will insurance cover GeneSight?
Coverage varies. Some government and commercial insurance plans provide coverage. Patient responsibility depends on the individual plan and other factors.
Will my psychiatric medications change my DNA test result?
Current medications do not change your underlying genetic test results, although medications, medical conditions, interactions, and other clinical factors remain important when interpreting treatment options.
Do I have to change my medication after testing?
No. Treatment decisions remain between you and your prescribing clinician.
Is GeneSight testing available through telehealth?
A psychiatric consultation to discuss whether pharmacogenomic testing may be appropriate can be completed by telehealth anywhere in Massachusetts or Rhode Island. Sample collection arrangements are confirmed with your provider.
Does GeneSight determine whether I am a candidate for Spravato?
No. Spravato (esketamine) eligibility is determined through psychiatric evaluation, diagnosis of treatment-resistant depression, prior medication trials, medical history, and insurance authorization where applicable. Pharmacogenomic testing is a separate consideration.
Explore Related Care
Medication Management
Psychiatric evaluation and ongoing medication management for children, adolescents, and adults.
Depression Treatment
Evaluation and treatment for depression, including care when previous medications have not been enough.
Spravato® for Depression
Supervised esketamine treatment in Stoughton for adults with treatment-resistant depression.
ADHD Evaluation & Treatment
Structured ADHD evaluation and medication management across Massachusetts and Rhode Island.
Anxiety Disorders
Assessment and treatment for generalized anxiety, panic, and related conditions.
Refer a Patient
Referral pathway for primary care, therapists, hospitals, and behavioral-health programs.
Talk With a Psychiatric Provider About Your Treatment Options
If medication selection or tolerability has been difficult, a psychiatric evaluation is the place to start. Your provider will tell you whether GeneSight pharmacogenomic testing may add useful information in your situation.
GeneSight testing does not identify a guaranteed effective medication and does not replace psychiatric evaluation or clinical judgment. GeneSight® is a registered trademark of Myriad Genetics. RayMex Wellness orders and clinically interprets testing when appropriate; the laboratory performs the genetic analysis.